Intermittent androgen suppression in the LuCaP 23.12 prostate cancer xenograft model
- 20 March 2000
- journal article
- research article
- Published by Wiley in The Prostate
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genesPublished by Elsevier ,2003
- Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot studyUrology, 1996
- Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castrationInternational Journal of Cancer, 1996
- Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour modelThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Intermittent androgen suppression in the treatment of prostate cancer: A preliminary reportUrology, 1995
- Prostate CancerEndocrinology and Metabolism Clinics of North America, 1994
- Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigenCancer, 1993
- Experimental Treatment of Prostatic Cancer by Intermittent Hormonal TherapyJournal of Urology, 1987
- Intermittent endocrine therapy for advanced prostate cancerCancer, 1986